Gray SJ - Search Results

1

Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

Powell SK, Rivera-Soto R, Gray SJ. Powell SK, et al. Among authors: gray sj. Discov Med. 2015 Jan;19(102):49-57. Discov Med. 2015. PMID: 25636961 Free PMC article. Review.

2

Optimizing gene delivery vectors for the treatment of heart disease.

Gray SJ, Samulski RJ. Gray SJ, et al. Expert Opin Biol Ther. 2008 Jul;8(7):911-22. doi: 10.1517/14712598.8.7.911. Expert Opin Biol Ther. 2008. PMID: 18549322 Review.

3

Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.

Hewitt FC, Li C, Gray SJ, Cockrell S, Washburn M, Samulski RJ. Hewitt FC, et al. Among authors: gray sj. J Virol. 2009 Apr;83(8):3919-29. doi: 10.1128/JVI.02466-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211760 Free PMC article.

4

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.

Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, Ehlers MD, Zylka MJ, McCown TJ, Samulski RJ. Gray SJ, et al. Hum Gene Ther. 2011 Sep;22(9):1143-53. doi: 10.1089/hum.2010.245. Epub 2011 Jun 1. Hum Gene Ther. 2011. PMID: 21476867 Free PMC article.

5

Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins.

Li C, Xiao P, Gray SJ, Weinberg MS, Samulski RJ. Li C, et al. Among authors: gray sj. Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14258-63. doi: 10.1073/pnas.1109522108. Epub 2011 Aug 15. Proc Natl Acad Sci U S A. 2011. PMID: 21844342 Free PMC article.

6

Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration.

Gray SJ, Choi VW, Asokan A, Haberman RA, McCown TJ, Samulski RJ. Gray SJ, et al. Curr Protoc Neurosci. 2011 Oct;Chapter 4:Unit 4.17. doi: 10.1002/0471142301.ns0417s57. Curr Protoc Neurosci. 2011. PMID: 21971848 Free PMC article.

7

Viral vectors for gene delivery to the central nervous system.

Lentz TB, Gray SJ, Samulski RJ. Lentz TB, et al. Among authors: gray sj. Neurobiol Dis. 2012 Nov;48(2):179-88. doi: 10.1016/j.nbd.2011.09.014. Epub 2011 Oct 7. Neurobiol Dis. 2012. PMID: 22001604 Free PMC article. Review.

8

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.

Bowles DE, McPhee SW, Li C, Gray SJ, Samulski JJ, Camp AS, Li J, Wang B, Monahan PE, Rabinowitz JE, Grieger JC, Govindasamy L, Agbandje-McKenna M, Xiao X, Samulski RJ. Bowles DE, et al. Among authors: gray sj. Mol Ther. 2012 Feb;20(2):443-55. doi: 10.1038/mt.2011.237. Epub 2011 Nov 8. Mol Ther. 2012. PMID: 22068425 Free PMC article. Clinical Trial.

9

Gene therapy and neurodevelopmental disorders.

Gray SJ. Gray SJ. Neuropharmacology. 2013 May;68:136-42. doi: 10.1016/j.neuropharm.2012.06.024. Epub 2012 Jun 27. Neuropharmacology. 2013. PMID: 22750077 Review.

10

Viral vectors and delivery strategies for CNS gene therapy.

Gray SJ, Woodard KT, Samulski RJ. Gray SJ, et al. Ther Deliv. 2010 Oct;1(4):517-34. doi: 10.4155/tde.10.50. Ther Deliv. 2010. PMID: 22833965 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page